Federated Hermes, Inc. 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-10 08:47 am Sale | 2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | FEDERATED HERMES INC. FHI | 3,094,500 4.410% | -892,370 (-22.38%) | Filing |
| 2022-02-14 3:02 pm Sale | 2021-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | FEDERATED HERMES INC. FHI | 3,986,870 5.850% | -293,658 (-6.86%) | Filing |
| 2021-02-12 1:06 pm Purchase | 2020-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | FEDERATED HERMES INC. FHI | 4,280,528 6.470% | 1,308,520 (+44.03%) | Filing |